Key statistics
As of last trade, Glaukos Corp (GKOS:NYQ) traded at 112.43, 53.68% above the 52 week low of 73.16 set on Oct 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 112.63 |
|---|---|
| High | 112.79 |
| Low | 111.54 |
| Bid | 112.08 |
| Offer | 112.78 |
| Previous close | 112.52 |
| Average volume | 745.06k |
|---|---|
| Shares outstanding | 57.43m |
| Free float | 55.54m |
| P/E (TTM) | -- |
| Market cap | 6.46bn USD |
| EPS (TTM) | -1.55 USD |
Data delayed at least 15 minutes, as of Feb 09 2026 14:51 GMT.
More ▼
- Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
- Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
- Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
- Glaukos Announces Participation in J.P. Morgan Healthcare Conference
